Randomized phase II trial of BCDT (carmustine, cisplatin, dacarbazine and tamoxifen) with or without interferon alpha and interleukin-2 in patients with metastatic melanoma

Search this article

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570572700103687936
  • NII Article ID
    10013030503
  • NII Book ID
    AA00574355
  • Data Source
    • CiNii Articles

Report a problem

Back to top